These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

312 related articles for article (PubMed ID: 34907483)

  • 1. Strategies for Liposome Drug Delivery Systems to Improve Tumor Treatment Efficacy.
    Wang J; Gong J; Wei Z
    AAPS PharmSciTech; 2021 Dec; 23(1):27. PubMed ID: 34907483
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Recent advances in liposome-based targeted cancer therapy.
    Fidan Y; Muçaj S; Timur SS; Gürsoy RN
    J Liposome Res; 2024 Jun; 34(2):316-334. PubMed ID: 37814217
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Updates on the use of liposomes for active tumor targeting in cancer therapy.
    Yan W; Leung SS; To KK
    Nanomedicine (Lond); 2020 Feb; 15(3):303-318. PubMed ID: 31802702
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Liposomes for Tumor Targeted Therapy: A Review.
    Wang S; Chen Y; Guo J; Huang Q
    Int J Mol Sci; 2023 Jan; 24(3):. PubMed ID: 36768966
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Progresses on active targeting liposome drug delivery systems for tumor therapy].
    Zhang M; Lou C; Cao A
    Sheng Wu Yi Xue Gong Cheng Xue Za Zhi; 2022 Jun; 39(3):633-638. PubMed ID: 35788534
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hyperthermia and thermosensitive liposomes for improved delivery of chemotherapeutic drugs to solid tumors.
    Koning GA; Eggermont AM; Lindner LH; ten Hagen TL
    Pharm Res; 2010 Aug; 27(8):1750-4. PubMed ID: 20424894
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Towards clinical translation of ligand-functionalized liposomes in targeted cancer therapy: Challenges and opportunities.
    Belfiore L; Saunders DN; Ranson M; Thurecht KJ; Storm G; Vine KL
    J Control Release; 2018 May; 277():1-13. PubMed ID: 29501721
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Nanocrystal-loaded liposome for targeted delivery of poorly water-soluble antitumor drugs with high drug loading and stability towards efficient cancer therapy.
    Liang H; Zou F; Liu Q; Wang B; Fu L; Liang X; Liu J; Liu Q
    Int J Pharm; 2021 Apr; 599():120418. PubMed ID: 33647414
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Future directions of liposome- and immunoliposome-based cancer therapeutics.
    Park JW; Benz CC; Martin FJ
    Semin Oncol; 2004 Dec; 31(6 Suppl 13):196-205. PubMed ID: 15717745
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Liposomes in Cancer Therapy: How Did We Start and Where Are We Now.
    Fulton MD; Najahi-Missaoui W
    Int J Mol Sci; 2023 Apr; 24(7):. PubMed ID: 37047585
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Liposomal Drug Delivery and Its Potential Impact on Cancer Research.
    Bhattacharya S; Saindane D; Prajapati BG
    Anticancer Agents Med Chem; 2022 Aug; 22(15):2671-2683. PubMed ID: 35440318
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Current trends in the use of liposomes for tumor targeting.
    Deshpande PP; Biswas S; Torchilin VP
    Nanomedicine (Lond); 2013 Sep; 8(9):1509-28. PubMed ID: 23914966
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Targeted thermosensitive liposomes: an attractive novel approach for increased drug delivery to solid tumors.
    Dicheva BM; Koning GA
    Expert Opin Drug Deliv; 2014 Jan; 11(1):83-100. PubMed ID: 24320104
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Trends and developments in liposome drug delivery systems.
    Lian T; Ho RJ
    J Pharm Sci; 2001 Jun; 90(6):667-80. PubMed ID: 11357170
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Novel drug delivery liposomes targeted with a fully human anti-VEGF165 monoclonal antibody show superior antitumor efficacy in vivo.
    Shi C; Cao H; He W; Gao F; Liu Y; Yin L
    Biomed Pharmacother; 2015 Jul; 73():48-57. PubMed ID: 26211582
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Integrin α
    Fu S; Zhao Y; Sun J; Yang T; Zhi D; Zhang E; Zhong F; Zhen Y; Zhang S; Zhang S
    Colloids Surf B Biointerfaces; 2021 May; 201():111623. PubMed ID: 33636597
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Liposomal drug delivery systems: an update review.
    Samad A; Sultana Y; Aqil M
    Curr Drug Deliv; 2007 Oct; 4(4):297-305. PubMed ID: 17979650
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Liposome size and charge optimization for intraarterial delivery to gliomas.
    Joshi S; Cooke JR; Chan DK; Ellis JA; Hossain SS; Singh-Moon RP; Wang M; Bigio IJ; Bruce JN; Straubinger RM
    Drug Deliv Transl Res; 2016 Jun; 6(3):225-33. PubMed ID: 27091339
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Targeted liposomal drug delivery in cancer.
    Medina OP; Zhu Y; Kairemo K
    Curr Pharm Des; 2004; 10(24):2981-9. PubMed ID: 15379663
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Advanced strategies in liposomal cancer therapy: problems and prospects of active and tumor specific drug release.
    Andresen TL; Jensen SS; Jørgensen K
    Prog Lipid Res; 2005 Jan; 44(1):68-97. PubMed ID: 15748655
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.